Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 3,105 | 2,360 | 1,277 | 1,135 | 1,373 |
| Gross Profit | 3,105 | 2,360 | 1,277 | 1,135 | 1,373 |
| Operating Expenses | 7,491 | 7,640 | 5,833 | 6,111 | 5,781 |
| Operating Income | -4,386 | -5,280 | -4,557 | -4,976 | -4,407 |
| Other Income | 1,964 | -1,029 | 3,142 | -2,638 | 2,107 |
| Pre-tax Income | -2,422 | -6,309 | -1,415 | -7,614 | -2,301 |
| Net Income Continuous | -2,422 | -6,309 | -1,415 | -7,614 | -2,301 |
| Minority Interests | -9 | -25 | 5 | 3 | -7 |
| Net Income | $-2,413 | $-6,284 | $-1,419 | $-7,616 | $-2,294 |
| EPS Basic Total Ops | -0.96 | -3.36 | -0.48 | -3.36 | -0.96 |
| EPS Basic Continuous Ops | -0.96 | -2.92 | -0.66 | -3.56 | -1.08 |
| EPS Diluted Total Ops | -0.96 | -3.36 | -0.48 | -3.36 | -0.96 |
| EPS Diluted Continuous Ops | -0.96 | -2.92 | -0.66 | -3.56 | -1.08 |
| EBITDA(a) | $-3,882 | $-4,754 | $-4,027 | $-4,446 | $-3,885 |